Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahoney

Showing results (361-370 of 409) with videos related to

Pageof 41
Sort By:
Plos One|October 8, 2014
Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injuryArya J Bahrami, Jagadambika J Gunaje, Brian J Hayes, et al.
BMC Cancer|October 27, 2023
Regulation of HHLA2 expression in kidney cancer and myeloid cellsTomonari Shigemura, Nahuel Perrot, Zimo Huang, et al.
Current Medical Research and Opinion|March 25, 2011
Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialNir Barzilai, Hua Guo, Erin M Mahoney, et al.
Journal of the American College of Cardiology|September 6, 2005
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialSean C Beinart, Paul Kolm, Emir Veledar, et al.
Tissue Engineering. Part A|March 23, 2021
Sustained Delivery of SB-431542, a Type I Transforming Growth Factor Beta-1 Receptor Inhibitor, to Prevent ArthrofibrosisAndy J Lee, Christopher M Mahoney, Charles C Cai, et al.
The Canadian Journal of Cardiology|April 5, 2011
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trialJersey Chen, Chunxue Shi, Elizabeth M Mahoney, et al.
Plos One|March 27, 2014
Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosisBrian J Hayes, Kimberly J Riehle, Masami Shimizu-Albergine, et al.
Annals of Internal Medicine|August 4, 2004
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach, Christopher P Cannon, William S Weintraub, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 26, 2011
Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trialElizabeth M Mahoney, Dan Greenberg, Tara A Lavelle, et al.
World Neurosurgery|July 23, 2021
Fixation Strength of Modified Iliac Screw Trajectory Compared to Traditional Iliac and S2 Alar-Iliac Trajectories: A Cadaveric StudyAlexander Von Glinski, Clifford Pierre, Sven Frieler, et al.
Pageof 41

Showing results (361-370 of 409) with videos related to

Sort By:
Pageof 41
Plos One|October 8, 2014
Regulator of G-protein signaling-5 is a marker of hepatic stellate cells and expression mediates response to liver injuryArya J Bahrami, Jagadambika J Gunaje, Brian J Hayes, et al.
BMC Cancer|October 27, 2023
Regulation of HHLA2 expression in kidney cancer and myeloid cellsTomonari Shigemura, Nahuel Perrot, Zimo Huang, et al.
Current Medical Research and Opinion|March 25, 2011
Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialNir Barzilai, Hua Guo, Erin M Mahoney, et al.
Journal of the American College of Cardiology|September 6, 2005
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialSean C Beinart, Paul Kolm, Emir Veledar, et al.
Tissue Engineering. Part A|March 23, 2021
Sustained Delivery of SB-431542, a Type I Transforming Growth Factor Beta-1 Receptor Inhibitor, to Prevent ArthrofibrosisAndy J Lee, Christopher M Mahoney, Charles C Cai, et al.
The Canadian Journal of Cardiology|April 5, 2011
Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trialJersey Chen, Chunxue Shi, Elizabeth M Mahoney, et al.
Plos One|March 27, 2014
Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosisBrian J Hayes, Kimberly J Riehle, Masami Shimizu-Albergine, et al.
Annals of Internal Medicine|August 4, 2004
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach, Christopher P Cannon, William S Weintraub, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 26, 2011
Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trialElizabeth M Mahoney, Dan Greenberg, Tara A Lavelle, et al.
World Neurosurgery|July 23, 2021
Fixation Strength of Modified Iliac Screw Trajectory Compared to Traditional Iliac and S2 Alar-Iliac Trajectories: A Cadaveric StudyAlexander Von Glinski, Clifford Pierre, Sven Frieler, et al.
Pageof 41